The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CELH, ABBV and MYPS Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BFLY, MP and ABBV Pharmaceutical Investing
AbbVie Presents Positive Investigational Navitoclax Combination Data in Phase 2 REFINE Study Suggesting Anti-Fibrosis Activity for Patients with Myelofibrosis Pharmaceutical Investing
ABBV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 6, 2022 in the Class Action Filed on Behalf of AbbVie Inc. Shareholders Pharmaceutical Investing
LAWSUITS FILED AGAINST ABBV, IBM and MYPS - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
CLASS ACTION UPDATE for AI, LCID and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
ABBV SHAREHOLDER ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Shareholder Action Alert: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
SHAREHOLDER ALERT: AI ABBV IBM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. and Encourages Investors with Significant Losses to Contact the Firm Pharmaceutical Investing
